British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.
作者信息
Williams Bryan, Poulter Neil R, Brown Morris J, Davis Mark, McInnes Gordon T, Potter John F, Sever Peter S, Thom Simon McG
机构信息
Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester.
出版信息
BMJ. 2004 Mar 13;328(7440):634-40. doi: 10.1136/bmj.328.7440.634.
Abstract
摘要
相似文献
1
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.
BMJ. 2004 Mar 13;328(7440):634-40. doi: 10.1136/bmj.328.7440.634.
2
Canadian Hypertension Education Program. Brief overview of 2004 recommendations.
Can Fam Physician. 2004 Oct;50:1411-5.
3
Prevention of cardiovascular events in diabetes.
Clin Evid. 2006 Jun(15):623-45.
4
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
Heart. 2005 Dec;91 Suppl 5(Suppl 5):v1-52. doi: 10.1136/hrt.2005.079988.
5
Prevention of cardiovascular events in diabetes.
Clin Evid. 2003 Dec(10):690-714.
6
New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
Curr Probl Cardiol. 2005 May;30(5):241-79. doi: 10.1016/j.cpcardiol.2004.10.001.
7
British Hypertension Society guidelines for hypertension management 1999: summary.
BMJ. 1999 Sep 4;319(7210):630-5. doi: 10.1136/bmj.319.7210.630.
8
[JNC 7].
Nihon Rinsho. 2006 Aug;64 Suppl 6:549-55.
9
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.
J Hum Hypertens. 2004 Mar;18(3):139-85. doi: 10.1038/sj.jhh.1001683.
10
Cardiometabolic risk-factor management.
Cardiovasc J Afr. 2008 Jul-Aug;19(4):222-4.
引用本文的文献
1
Early diagnosis of coronary heart disease based on retinal microvascular parameters of OCTA.
Front Cell Dev Biol. 2025 Aug 12;13:1654159. doi: 10.3389/fcell.2025.1654159. eCollection 2025.
2
Large inter-arm systolic blood pressure difference is associated with cognitive impairment in older adults: a cross-sectional study in rural southwest China.
Front Aging Neurosci. 2025 Apr 14;17:1489033. doi: 10.3389/fnagi.2025.1489033. eCollection 2025.
3
Prevalence of adverse cardiometabolic health markers in UK undergraduate university students: an observational cohort study.
BMJ Open. 2025 Apr 27;15(4):e089771. doi: 10.1136/bmjopen-2024-089771.
4
Use of Quadruple Therapy in the Management of Hypertension: A Systematic Review of Randomized Controlled Trials.
Medicina (Kaunas). 2025 Apr 21;61(4):764. doi: 10.3390/medicina61040764.
5
Accelerating inflammatory resolution in humans to improve endothelial function and vascular health: Targeting the non-canonical pathway for NO.
Redox Biol. 2025 May;82:103592. doi: 10.1016/j.redox.2025.103592. Epub 2025 Mar 28.
6
Prediction of Hypertension in the Pediatric Population Using Machine Learning and Transfer Learning: A Multicentric Analysis of the SAYCARE Study.
Int J Public Health. 2025 Mar 11;70:1607944. doi: 10.3389/ijph.2025.1607944. eCollection 2025.
7
Non-Contact Optical Blood Pressure Biometry Using AI-Based Analysis of Non-Mydriatic Fundus Imaging.
medRxiv. 2025 Jan 7:2025.01.06.25320084. doi: 10.1101/2025.01.06.25320084.
8
Longitudinal analysis of blood pressure control and influencing factors among 32 701 primary care hypertensive patients with or without diabetes: a prospective cohort study in Jianye District, China.
Int Health. 2025 Jul 1;17(4):461-469. doi: 10.1093/inthealth/ihae082.
9
Dietary Intake Is Similar Among Adult Men with Different Levels of Cold-Induced Brown Adipose Tissue Activation.
Nutrients. 2024 Oct 30;16(21):3697. doi: 10.3390/nu16213697.
10
A Continuous Non-Invasive Blood Pressure Prediction Method Based on Deep Sparse Residual U-Net Combined with Improved Squeeze and Excitation Skip Connections.
Sensors (Basel). 2024 Apr 24;24(9):2721. doi: 10.3390/s24092721.
本文引用的文献
1
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.
J Hum Hypertens. 2004 Mar;18(3):139-85. doi: 10.1038/sj.jhh.1001683.
2
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
Lancet. 2003 Nov 8;362(9395):1527-35. doi: 10.1016/s0140-6736(03)14739-3.
3
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.
J Hypertens. 2003 Jun;21(6):1011-53. doi: 10.1097/00004872-200306000-00001.
4
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement.
J Hypertens. 2003 May;21(5):821-48. doi: 10.1097/00004872-200305000-00001.
5
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0.
6
Better blood pressure control: how to combine drugs.
J Hum Hypertens. 2003 Feb;17(2):81-6. doi: 10.1038/sj.jhh.1001511.
7
Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program.
JAMA. 2002 Oct 16;288(15):1882-8. doi: 10.1001/jama.288.15.1882.
8
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Lancet. 2002 Jul 6;360(9326):7-22. doi: 10.1016/S0140-6736(02)09327-3.
9
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3.
10
Improved hypertension management and control: results from the health survey for England 1998.
Hypertension. 2001 Oct;38(4):827-32.
Zotero 插件